Neuroendocrine Cancer clinical trials in Australia
6 neuroendocrine cancer trials recruiting in Australia
Neuroendocrine tumours and carcinomas encompass a diverse group of cancers. Areas of active research include peptide receptor radionuclide therapy (PRRT), targeted therapies, and immunotherapy.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your neuroendocrine cancer in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting neuroendocrine cancer trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Neuroendocrine Cancer clinical trials: common questions
The things people most often ask about neuroendocrine cancer trials.
Neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs) both arise from hormone-producing cells found throughout the body, but they behave very differently. NETs tend to be well-differentiated and slower growing, and are graded 1, 2, or 3. NECs are poorly differentiated and grow much more aggressively. The two are studied as separate diseases because they respond to different families of treatment.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.